Humacyte Inc. (NASDAQ: HUMA) Stock Information | RedChip

Humacyte Inc. (NASDAQ: HUMA) Listen to this Section


$6.48
+0.3400 ( +5.54% ) 3.0M

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Market Data


Open


$6.48

Previous close


$6.14

Volume


3.0M

Market cap


$773.40M

Day range


$6.13 - $6.69

52 week range


$1.96 - $9.97

Insider Ownership Transactions

Total Amount Purchased: -6,511,926.00 | $ -42,197,280.48

Date Type Amount Purchased Purchaser
2023-12-12 Sale -290000.00 Prichard Heather Ledbetter
2023-12-12 Sale -276000.00 Scheessele William John
2023-11-21 Sale -6564.00 Wallace Max N.
2023-10-10 Sale -114420.00 Niklason Laura E
2023-10-10 Sale -114420.00 Dougan Brady W
2023-09-15 Sale -2000000.00 Niklason Laura E
2023-09-15 Sale -2000000.00 Dougan Brady W
2023-08-21 Sale -570174.00 Niklason Laura E
2023-08-21 Sale -570174.00 Dougan Brady W
2023-08-21 Sale -570174.00 Ayabudge LLC

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 20, 2024
4 Insider transactions 1 May 15, 2024
10-q Quarterly Reports 76 May 13, 2024
8-k 8K-related 16 May 10, 2024
def Proxies and info statements 6 Apr 29, 2024
10-k Annual reports 129 Mar 28, 2024
8-k 8K-related 16 Mar 22, 2024
8-k 8K-related 22 Mar 04, 2024
8-k 8K-related 57 Feb 29, 2024
8-k 8K-related 17 Feb 09, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.